This drug is a true gamechanger
In the SURMOUNT-1 study, people who took the highest dose of tirzepatide, most of whom had a BMI of about 30 or higher but did not have diabetes, lost about 21% of their body weight during the 72 week study. As researchers point out, for people who have bariatric surgery, typical weight loss is about 25% to 30% of their weight, one or two years after the surgery. In the tirzepatide study, 36% of people taking the highest dose lost 25% or more of their body weight.
this is comparable to bariatric surgery
Jump in the discussion.
No email address required.
Notes -
The vast majority of cancer therapy will boost your expected lifespan on the order of months to a few years. Cures are quite rare and usually surgical in nature except for some slower growing cancers or newer immunotherapies.
Pharma companies just change their prices accordingly if you're only taking the drug for a few months. It's unfortunately arbitrary and pretty disconnected from actual benefit conferred to the patient.
More options
Context Copy link